Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdomyosarcoma × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 137 Leukemia 64 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Leukemia, Myelomonocytic, Acute 26 Leukemia, Monocytic, Acute 26 Leukemia, Erythroblastic, Acute 23 Leukemia, Megakaryoblastic, Acute 22 Myelodysplastic Syndromes 21 Congenital Abnormalities 19 Leukemia, Promyelocytic, Acute 12 Leukemia, Myelomonocytic, Chronic 11 Anemia, Refractory, with Excess of Blasts 11 Recurrence 8 Myeloproliferative Disorders 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Eosinophilic, Acute 7 Carcinoma, Hepatocellular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Biphenotypic, Acute 6 Leukemia, Basophilic, Acute 6 Lymphoma 5 Neoplasm, Residual 4 Multiple Myeloma 4 Blast Crisis 4 Neutropenia 3 Neoplasms, Plasma Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Liver Neoplasms 3 Leukemia, Myeloid, Accelerated Phase 3 Neoplasms 2

Interventions

Cyclophosphamide 23 Vincristine 21 Irinotecan 20 Temozolomide 17 Doxorubicin 14 Radiotherapy 13 Filgrastim 13 Ifosfamide 12 Dactinomycin 12 Etoposide 10 Granulocyte Colony-Stimulating Factor 9 Melphalan 8 Magnetic Resonance Spectroscopy 8 pegfilgrastim 7 Vinorelbine 7 Sirolimus 7 Radiation 7 X-Rays 6 Topotecan 6 Specimen Handling 6 fludarabine 5 cixutumumab 5 Phantoms, Imaging 5 Gemcitabine 5 Busulfan 5 temsirolimus 4 fludarabine phosphate 4 etoposide phosphate 4 Thiotepa 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡